Benzinga | Sep 8, 2020 12:34PM EDT

RBC Capital Downgrades Corbus Pharmaceuticals to Sector Perform

RBC Capital analyst Brian Abrahams downgrades Corbus Pharmaceuticals (NASDAQ:CRBP) from Outperform to Sector Perform.